Der Schmerz

, Volume 4, Issue 3, pp 166–172 | Cite as

Die Salicylate

  • E. Hackenthal
Das Medikamen


Die Salicylate gehören zu den ältesten chemisch definierten Analgetika (Einführung der Salicylsäure 1875, der Acetylsalicylsäure 1899) und sind auch heute noch die am häufigsten verwendeten Schmerz- und Fiebermittel. Zur Gruppe der Salicylate werden—neben Acetylsalicylsäure und Salicylsäure—Salicylamid, Benorilat, Diflunisal, Salicylsalicylat und Gentisinsäure gerechnet. Da in der praktischen Anwendung der Acetylsalicylsäure und ihrem Hauptmetaboliten,—der Salicylsäure—die größte Bedeutung zukommen, werden zunächst die Eigenschaften dieser beiden Substanzen und anschließend die der anderen Salicylate vergleichend dargestellt.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abramson S, Korchak H, Ludewig R et al. (1985) Modes of action of aspirinlike drugs. Proc Natl Acad Sci USA 82:7227PubMedCrossRefGoogle Scholar
  2. 2.
    Arrowsmith J, Kennedy D, Kuritsky J, Faich G (1987) National patterns of aspirin use and Reye syndrome reporting, United States 1980–1985. Pediatrics 79:858PubMedGoogle Scholar
  3. 3.
    Asad ST, Kemeny DM, Youlten LJF, Frankland AW, Lessof MH (1984) Effect of aspirin in “aspirin sensitive” patients. Br Med J 288:745Google Scholar
  4. 4.
    Barr WH (1969) Factors involved in the assessment of systemic and biological availability of drug products. Drug Inf Bull 3:27Google Scholar
  5. 5.
    Batterman RC, Grossman AJ (1955) Effectiveness of salicylamide as an analgesic and antirheumatic. JAMA 159:1619Google Scholar
  6. 6.
    Bochner F, Lloyd J (1986) Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man? Clin Sci 71:625PubMedGoogle Scholar
  7. 7.
    Borovsky MP (1960) Antipyrotic activity of acetylsalicylic acid and salicyl amide suspension in pediatrics. Am J Dis Child 100:23PubMedGoogle Scholar
  8. 8.
    Brenner BE, Simon RR (1982) Management of salicylate intoxication. Drugs 24:335PubMedGoogle Scholar
  9. 9.
    Brogden RN (1986) Non-steroidal antiinflammatory analgesics other than salicylates. Drugs 32 [Suppl 4]:27PubMedGoogle Scholar
  10. 10.
    Brodgen RN, Heel RC, Pake GE, Speight TM, Avery GS (1980) Diflunisal: a review of its pharmacological properties and therapeutic use in pain and musculosceletal strains and sprains and pain in osteoarthritis. Drugs 19:84Google Scholar
  11. 11.
    Brune K (1983) Prostaglandins and the mode of action of antipyretic analgesic drugs. Am J Med 75:19PubMedCrossRefGoogle Scholar
  12. 12.
    Brune K, Lanz R (1984) Mode of action of peripheral analgesics. Arzneimittelforschung 34:1060PubMedGoogle Scholar
  13. 13.
    Brune K, Lanz R (1985) Pharmacokinetics of non-steroidal antiinflammatory drugs. In: Bonta IL, Bray MA, Parnham MJ (eds) Handbook of inflammation: the Pharmacology of inflammation. Elsevier Science, Amsterdam, p 413Google Scholar
  14. 14.
    Carlsson K-H, Monzel W, Jurna I (1988) Depression by morphine and the non-opioid analgesic agents, metamizol (dipyrone), lysine acetylsalicylate, and paracetamol, of activity in rat thalamus neurones evoked by electrical stimulation of nociceptive afferents. Pain 32:313PubMedCrossRefGoogle Scholar
  15. 15.
    Clissold SP (1986) Aspirin and related derivatives of salicylic acid. Drugs 32 [Suppl 4]:8PubMedGoogle Scholar
  16. 16.
    Clive DM, Stoff JS (1984) Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 310:563PubMedCrossRefGoogle Scholar
  17. 17.
    Cooper KE, Veale WL, Kasting NW (1982) Temperature regulation, fever, and antipyretics. In: Barnett HJM, Hirsh J, Mustard JF (eds) Acetylsalicylic acid: new uses for an old drug. Raven, New York, p 153Google Scholar
  18. 18.
    Croft DN, Cuddigan JHP, Sweetland C (1972) Gastric bleeding and benorylate, a new aspirin. Br Med J 3:545PubMedCrossRefGoogle Scholar
  19. 19.
    Devoghel JC (1983) Small intrathecal doses of lysine-acetylsalicylate relieve intractable pain in man. J Int Med Res 11:90PubMedGoogle Scholar
  20. 20.
    Dromgoole SH, Casell S, Furst DE, Paulus HE (1983) Availability of salicylate from salsalate and aspirin. Clin Pharmacol Ther 34:539PubMedCrossRefGoogle Scholar
  21. 21.
    Ferreira SH, Lorenzetti BB, Correa FMA (1978) Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol 53:39PubMedCrossRefGoogle Scholar
  22. 22.
    Fjalland B (1974) Inhibition by nonsteroidal anti-inflammatory agents of the release of rabbit aorta contracting substance and prostaglandins from chopped guinea pig lungs. J Pharm Pharmacol 26:448PubMedGoogle Scholar
  23. 23.
    Fleckenstein L, Mundy GR, Horovitz KA, Mazzullo IM (1976) Sodium salicylamide: relative bioavailability and subjective effects. Clin Pharmacol Ther 19:451PubMedGoogle Scholar
  24. 24.
    Flower RJ, Vane JR (1972) Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature 240:410PubMedCrossRefGoogle Scholar
  25. 25.
    Fox JM (1988) Coffein plus Analgetika —eine sinnvolle Kombination. Schmerz 2:183CrossRefPubMedGoogle Scholar
  26. 26.
    Gibaldi M, Grundhofer B (1975) Bioavailability of aspirin from commercial suppositories. J Pharm Sci 64:1064PubMedCrossRefGoogle Scholar
  27. 27.
    Gladtke E, Schauseil-Zipf U (1987) Reye-Syndrom. Monatsschr Kinderheilkd 135:699PubMedGoogle Scholar
  28. 28.
    Griffiths RR, Bigelow GE, Liebson IA (1986) Human coffee drinking: reinforcing and physical dependence producing effects of caffeine. J Pharmacol Exp Ther 239:416PubMedGoogle Scholar
  29. 29.
    Güller R (1987) Die Nebenwirkungen nicht-steroidaler Antirheumatika im unteren Gastrointestinaltrakt. Schweiz Med Wochenschr 117:1527PubMedGoogle Scholar
  30. 30.
    Hackenthal E, Wörz R (1985) Analgetika: Irrationale Anwendung, Mißbrauch und Abhängigkeit. In: Hackenthal E, Wörz R (Hrsg) Medikamentöse Schmerzbehandlung in der Praxis. G. Fischer, Stuttgart, S 325Google Scholar
  31. 31.
    Hennekens CH, Buring JE, Sandercock P, Collins R, Peto R (1989) Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. Circulation 80:749PubMedGoogle Scholar
  32. 32.
    Heppelmann B, Pfeffer A, Schaible H-G, Schmidt RF (1986) Effects of acetylsalicylic acid and indomethacin on single groups III and IV sensory units from acutely inflamed joints. Pain 26:337PubMedCrossRefGoogle Scholar
  33. 33.
    Heymann MA (1986) Non-narcotic analgesics: Use in pregnancy and fetal and perinatal effects. Drugs 32 [Suppl 4]:164PubMedGoogle Scholar
  34. 34.
    Higgs GA, Salmon JA, Henderson B, Vane JR (1987) Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity. Proc Natl Acad Sci USA 84:1417PubMedCrossRefGoogle Scholar
  35. 35.
    Hurwitz ES, Barrett JM, Bregman D (1987) Public health service study of Reye’s syndrome and medications. Report of the main study. JAMA 257:1905PubMedCrossRefGoogle Scholar
  36. 36.
    Ivey KJ (1986) Gastrointestinal intolerance and bleeding with non-narcotic analgesics. Drugs 32 [Suppl 4]:71PubMedGoogle Scholar
  37. 37.
    Jakubowski JA, Stampfer MJ, Vaillancourt R, Faigel D, Deykin D (1986) Low-dose enteric coated aspirin: A practical approach to continuous-release low-dose aspirin and presystemic acetylation of human platelet cyclooxigenase. J Lab Clin Med 108:616PubMedGoogle Scholar
  38. 38.
    Jick H (1982) Adverse effects of acetylsalicylic acid. In: Barnett HJM, Hirsh JF (eds) Acetylsalicylic acid: new uses for an old drug. Raven, New York, p 239Google Scholar
  39. 39.
    Kincaid-Smith P (1986) Effects of nonnarcotic analgesics on the kidney. Drugs 32 [Suppl 4]:109PubMedGoogle Scholar
  40. 40.
    Kwoh CK, Feinstein AR (1986) Rates of sensitivity reactions to aspirin: problems in interpreting the data. Clin Pharmacol Ther 40:494PubMedCrossRefGoogle Scholar
  41. 41.
    Lanz R, Polster P, Brune K (1986) Antipyretic analgesics inhibit prostaglandin release from astrocytes and macrophages similarly. Eur J Pharmacol 130:105PubMedCrossRefGoogle Scholar
  42. 42.
    Laska EM, Sunshine A, Mueller F, Elvers WB, Siegel C, Rubin A (1984) Caffeine as an analgesic adjuvant. JAMA 251:1711PubMedCrossRefGoogle Scholar
  43. 43.
    Levy G (1980) Clinical pharmacokinetics of salicylates: a re-assessment. Br J Clin Pharmacol 10:285Google Scholar
  44. 44.
    Litter M, Moreno AR, Dorin L (1951) Salicylamide: pharmacology, fate and clinical use. J Pharmacol Exp Ther 101:119PubMedGoogle Scholar
  45. 45.
    Madhok R, McKenzie JA, Lee FD, Bruckner FE, Terry TR, Sturrock RD (1986) Small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs for rheumatoid arthritis. Q J Med 58:53PubMedGoogle Scholar
  46. 46.
    McCarthy DJ, Csuka M (1987) Aspirin in the treatment of chronic inflammatory arthritis. JAMA 257:1327CrossRefGoogle Scholar
  47. 47.
    Meffin PJ, Brooks PM, Bertouch J, Veenendahl JR, Harrington BJ (1983) Diflunisal disposition and hypouricemic response in osteoarthritis. Clin Pharmacol Ther 33:813PubMedCrossRefGoogle Scholar
  48. 48.
    Mielke CH (1981) Comparative effects of aspirin and acetaminophen on hemostasis. Arch Intern Med 141:305PubMedCrossRefGoogle Scholar
  49. 49.
    Mitchell D, Laburn HP, Cooper KE, Hellon RF, Cranston WI, Townsend Y (1986) Is prostaglandin E the neural mediator of the febrile response? The case against a proven obligatory role. Yale J Biol Med 59:159PubMedGoogle Scholar
  50. 50.
    Needs CJ, Brooks PM (1985) Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet 10:164PubMedGoogle Scholar
  51. 51.
    Packham MA (1982) Mode of action of acetylsalicylic acid. In: Barnett HJM, Hirsh J, Mustard JF (eds) Acetylsalicylic acid: new uses for an old drug. Raven, New York, p 63Google Scholar
  52. 52.
    Patrono C (1989) Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back. Trends Pharmacol Sci 10:453PubMedCrossRefGoogle Scholar
  53. 53.
    Pedersen AK, Fitzgerald GA (1984) Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxigenase. N Engl J Med 311:1206PubMedCrossRefGoogle Scholar
  54. 54.
    Pedersen AK, Fitzgerald GA (1985) The human pharmacology of platelet inhibition: pharmacokinetics relevant to drug action. Circulation 72:1164PubMedGoogle Scholar
  55. 55.
    Pommer W, Glaeske G, Molzahn M (1987) Analgetika-Verbrauch in der Bundesrepublik Deutschland Ausmaß and Risikogruppen. Tnsein Med Wochenschr 112:787Google Scholar
  56. 56.
    Prescott LF (1986) Effects of non-narcotic analgesics on the liver. Drugs 32 [Suppl 4]:129PubMedGoogle Scholar
  57. 57.
    Rainsford KD (1984) Aspirin and the salicylates. Butterworths, London BostonGoogle Scholar
  58. 58.
    Rainsford KD, Schweitzer A, Brune K (1983) Distribution of the acetyl compared with the salicyl moity of acetylsalicylic acid. Biochem Pharmacol 32:1301PubMedCrossRefGoogle Scholar
  59. 59.
    Rampton DS (1987) Non-steroidal antiinflammatory drugs and the lower gastrointestinal tract. Scand J Gastroenterol 22:1PubMedGoogle Scholar
  60. 60.
    Remington PL, Rowley D, McGee H, Hall WN, Monto AS (1986) Decreasing trends in Reye syndrome and aspirin use in Michigan, 1979 to 1984. Pediatrics 77:93PubMedGoogle Scholar
  61. 61.
    Reynolds JEF (1982) Benorilate. In: Martindale The Extra Pharmacopoeia, 28th edn. Pharmaceutical Press, London, p 246Google Scholar
  62. 62.
    Roth GJ, Siok CJ (1978) Acetylation of the NH2-terminal serine of prostaglandin synthetase by aspirin. J Biol Chem 253:3782PubMedGoogle Scholar
  63. 63.
    Rowland M, Riegelman S (1968) Pharmacokinetics of acetylsalicylic acid and salicylic acid after intravenous administration in man. J Pharm Sci 57:1313CrossRefGoogle Scholar
  64. 64.
    Rowland M, Riegelman S, Harris PA, Sholkoff SD (1972) Absorption kinetics of aspirin in man following oral administration of an aqueous solution. J Pharm Sci 61:379PubMedCrossRefGoogle Scholar
  65. 65.
    Schwartz HA (1981) Lower gastrointestinal side effects of nonsteroidal antiinflammatory drugs. J Rheumatol 8:952PubMedGoogle Scholar
  66. 66.
    Schwartz A, Faber U, Glaeske G, Keller F, Offermann G, Pommer W, Molzahn M (1985) Daten zu Analgetika-Konsum und Analgetika-Nephropathie in der Bundesrepublik. Off Gesundheitswes 47:298Google Scholar
  67. 67.
    Settipane GA (1983) Aspirin and allergic disease: a review. Am J Med 74:102PubMedCrossRefGoogle Scholar
  68. 68.
    Seymour RA, Williams FM, Rawlins MD (1984) Aspirin metabolism and efficacy in postoperative dental pain. Br J Clin Pharmacol 17:698Google Scholar
  69. 69.
    Silverstein FE, Robinson DR (eds) (1988) Proceedings of a symposium: nonsteroidal anti-inflammatory drug-induced gastrointestinal damage. Am J Med 84:1Google Scholar
  70. 70.
    Smith MJH (1978) Aspirin and prostaglandins, some recent developments. Agents Actions 8:427PubMedCrossRefGoogle Scholar
  71. 71.
    Smith MJH, Ford-Hutchinson AW, Walker JR, Slack JA (1979) Aspirin, salicylate and prostaglandins. Agents Actions 9:483PubMedCrossRefGoogle Scholar
  72. 72.
    Song CS, Gelb NA, wolff SM (1972) The influence of pyrogen-induced fever on salicylamide metabolism in man. J Clin Invest 51:2959PubMedCrossRefGoogle Scholar
  73. 73.
    Späth G (1982) Vergiftungen und akute Arzneimittelüberdosierungen. de Gruyter, BerlinGoogle Scholar
  74. 74.
    Stevenson DD (1984) Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 74:617PubMedCrossRefGoogle Scholar
  75. 75.
    Stuart MJ, Gross SJ, Elrad H, Graeber JE (1982) Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis. N Engl J Med 307:909PubMedCrossRefGoogle Scholar
  76. 76.
    Szczeklik A (1986) Analgesics, allergy and asthma. Drugs 32 [Suppl 4]:148PubMedGoogle Scholar
  77. 77.
    Szczeklik A, Gryglewski RJ (1983) Asthma and anti-inflammatory drugs. Mechanisms and clinical patterns. Drugs 25:533PubMedGoogle Scholar
  78. 78.
    Thiessen JJ (1982) Pharmacokinetics of salicylates. In: Barnett HJM, Hirsh J, Mustard JF (eds) Acetylsalicylic acid. New uses for an old drug. Raven, New York, p 49Google Scholar
  79. 79.
    Tolman EL, Partridge R (1975) Multiple sites of interactions between prostaglandins and non-steroidal anti-inflammatory agents. Prostaglandins 9:349PubMedCrossRefGoogle Scholar
  80. 80.
    Uribe A, Johansson C, Slezak P, Rubio C (1986) Ulcerations of the colon associated with naproxon and acetylsalicylic acid treatment. Gastrointest Endosc 32:242PubMedCrossRefGoogle Scholar
  81. 81.
    Von Bruchhausen F, Baumann J (1982) Inhibitory actions of desacetylation products of phenacetin and paracetamol on prostaglandin synthetases in neuronal and glial cell lines and rat renal medulla. Life Sci 30:1783CrossRefGoogle Scholar
  82. 82.
    Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of aspirin-like drugs. Nature (New Biol) 231:232Google Scholar
  83. 83.
    Vane JR (1987) The evolution of non-steroidal anti-inflammatory drugs and their mechanism of action. Drugs 33 [Suppl 1]:18PubMedGoogle Scholar
  84. 84.
    Ventafridda V, Tamburini M, Caraceni A, DeConno F, Nabli F (1987) Avalidation study of the WHO method for cancer pain relief. Cancer 59:850PubMedCrossRefGoogle Scholar
  85. 85.
    Vignec AJ, Gasparik M (1958) Antipyretic effectiveness of salicylamide and acetylsalicylic acid in infants. JAMA 167:1821Google Scholar
  86. 86.
    Wallenstein SL, Houde RW (1954) Clinical comparison of the analgesic effectiveness of N-acetyl-p-aminophenol, salicylamide and aspirin. Fed Proc 13:414Google Scholar
  87. 87.
    Yaksh TL (1982) Central and peripheral mechanisms for the antialgesic action of acetylsalicylic acid. In: Barnett HJM, Hirsh J, Mustard JF (eds) Acetylsalicylic acid: new uses for an old drug. Raven, New York, p 137Google Scholar
  88. 88.
    Zimmermann HJ (1981) Effects of aspirin and acetaminophen on the liver. Arch Intern Med 141:333CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • E. Hackenthal
    • 1
  1. 1.Pharmakologisches Institut der UniversitätHeidelberg 1

Personalised recommendations